Litcius/Paper detail

The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases

Ming‐Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang, Ying‐Cheng Chiang

2024Pharmaceuticals36 citationsDOIOpen Access PDF

Abstract

Chitinase-3-like protein-1 (CHI3L1), also known as YKL40, is a glycoprotein that belongs to the chitinase protein family. It is involved in various biological functions, including cell proliferation and tissue remodeling, with inflammatory and immunomodulatory capabilities. Several studies have shown that CHI3L1(YKL40) is upregulated in various diseases, such as cancer, asthma, and inflammatory bowel disease, among others. Although the expression level of CHI3L1(YKL40) is associated with disease activity, severity, and prognosis, its potential as a therapeutic target is still under investigation. In this review, we summarize the biological functions, pathological roles, and potential clinical applications of specific inhibitors and targeted therapies related to CHI3L1(YKL40).

Topics & Concepts

ChitinaseDiseaseInflammationCancerPathologicalMedicineCancer researchInflammatory bowel diseaseGlycoproteinBioinformaticsImmunologyBiologyPathologyInternal medicineEnzymeBiochemistryMolecular biologyStudies on Chitinases and ChitosanasesInsect symbiosis and bacterial influencesPeptidase Inhibition and Analysis
The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases | Litcius